P7 Are women commencing Neoadjuvant Chemotherapy (NAC) for Primary Breast Cancer (PBC) more likely to experience distress compared to women undergoing surgical intervention or Adjuvant Chemotherapy (AC)?
Main Authors: | R.L. Hay, E. Pascoe |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-04-01
|
Series: | Breast |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0960977620300229 |
Similar Items
-
The Aetiology of Delay to Commencement of Adjuvant Chemotherapy following Colorectal Resection
by: G. S. Simpson, et al.
Published: (2014-01-01) -
Adjuvant and neoadjuvant chemotherapy in pancreatic ductal adenocarcinoma
by: Carl S. Leonhardt, MD, et al.
Published: (2020-03-01) -
Resistance to neoadjuvant chemotherapy (NAC) in women with Breast cancer : Proteomic signatures in predicting likely response to nac and breast cancer stem cells as key factors in induction of resistance
by: Chuthapisith, Suebwong
Published: (2008) -
Inulin Supplementation Reduces Systolic Blood Pressure in Women with Breast Cancer Undergoing Neoadjuvant Chemotherapy
by: Yizel Becerril-Alarcón, et al.
Published: (2019-01-01) -
Neoadjuvant and Adjuvant Chemotherapy in Osteosarcoma (The Experience of HORC in the Shariati Hospital)
by: Alimoghadam K, et al.
Published: (2004-07-01)